BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8503693)

  • 1. Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales.
    Bergh K; Iversen OJ; Lysvand H
    Arch Dermatol Res; 1993; 285(3):131-4. PubMed ID: 8503693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.
    Takematsu H; Tagami H
    Arch Dermatol; 1993 Jan; 129(1):74-80. PubMed ID: 8420495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma.
    Bergh K; Iversen OJ
    J Immunol Methods; 1992 Jul; 152(1):79-87. PubMed ID: 1379278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability over time of complement activation induced by air bubbles in human and rabbit sera.
    Bergh K; Hjelde A; Iversen OJ; Brubakk AO
    J Appl Physiol (1985); 1993 Apr; 74(4):1811-5. PubMed ID: 8514700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies.
    Takeda J; Kinoshita T; Takata Y; Kozono H; Tanaka E; Hong K; Inoue K
    J Immunol Methods; 1987 Aug; 101(2):265-70. PubMed ID: 3611800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive enzyme immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope.
    Oppermann M; Schulze M; Götze O
    Complement Inflamm; 1991; 8(1):13-24. PubMed ID: 1710957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.
    Rainard P; Sarradin P; Paape MJ; Poutrel B
    Vet Res; 1998; 29(1):73-88. PubMed ID: 9559522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a.
    Bergh K; Iversen OJ
    Scand J Immunol; 1989 Mar; 29(3):333-41. PubMed ID: 2470136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
    Yancey KB; Lawley TJ; Dersookian M; Harvath L
    J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    Senior RM; Griffin GL; Perez HD; Webster RO
    J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR; Chenoweth DE; Goldstein IM; Perez HD
    J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of psoralen + ultraviolet-A on the chemotactic activity of polymorphonuclear neutrophils towards anaphylatoxin C5a des Arg.
    Esaki K; Mizuno N
    Photochem Photobiol; 1992 May; 55(5):783-8. PubMed ID: 1528990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5 neoepitopes appearing during activation.
    Inoue K
    Complement Inflamm; 1989; 6(3):219-22. PubMed ID: 2472923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific enzyme-linked immunosorbent assay (ELISA) for the determination of human C5a antigen.
    Kunkel SL; Manderino GL; Marasco W; Kaercher K; Hirata AA; Ward PA
    J Immunol Methods; 1983 Sep; 62(3):305-14. PubMed ID: 6193199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography.
    Manderino GL; Suarez AF; Kunkel SL; Ward PA; Hirata AA; Showell H
    J Immunol Methods; 1982 Aug; 53(1):41-50. PubMed ID: 6752282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-acid sequence and disulfide linkages of the anaphylatoxin, des-Arg omega-C5a, from porcine serum.
    Zimmermann B; Vogt W
    Hoppe Seylers Z Physiol Chem; 1984 Feb; 365(2):151-8. PubMed ID: 6714942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gc globulin (vitamin D-binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: an explanation for its cochemotaxin activity.
    Perez HD
    Inflammation; 1994 Apr; 18(2):215-20. PubMed ID: 8070905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
    Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
    Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).
    Perez HD; Kelly E; Chenoweth D; Elfman F
    J Clin Invest; 1988 Jul; 82(1):360-3. PubMed ID: 3392212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.